摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl 4-(2-chlorophenyl)-4-hydroxypiperidine-1-carboxylate | 864829-99-2

中文名称
——
中文别名
——
英文名称
benzyl 4-(2-chlorophenyl)-4-hydroxypiperidine-1-carboxylate
英文别名
——
benzyl 4-(2-chlorophenyl)-4-hydroxypiperidine-1-carboxylate化学式
CAS
864829-99-2
化学式
C19H20ClNO3
mdl
——
分子量
345.826
InChiKey
ITYLYCBLXYXONJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    508.5±50.0 °C(Predicted)
  • 密度:
    1.293±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Cycloalkanopyridine derivative
    申请人:Takahashi Hirobumi
    公开号:US20070191419A1
    公开(公告)日:2007-08-16
    Provided are cycloalkanopyridine derivatives of formula [I]: [wherein the symbols are the same as those stated in the description]. The compounds act as a nociceptin receptor antagonist, and are useful as medicines for diseases associated with a nociceptin receptor, for example, as a reliever against tolerance to a narcotic analgesic; a reliever against dependence on or addiction to a narcotic analgesic; an analgesic enhancer; an antiobesitic or appetite suppressor; a treating or prophylactic agent for cognitive impairment and dementia/amnesia; an agent for treating developmental cognitive abnormality; a remedy for schizophrenia; an agent for treating neurodegenerative diseases; an anti-depressant or treating agent for affective disorder; a treating or prophylactic agent for diabetes insipidus; a treating or prophylactic agent for polyuria; or a remedy for hypotension.
    提供的是式[I]的环烷基吡啶衍生物:[其中符号与说明中所述相同]。这些化合物作为一种nociceptin受体拮抗剂,可用作与nociceptin受体相关的疾病的药物,例如作为缓解对麻醉镇痛剂的耐受性的药物;对麻醉镇痛剂的依赖或成瘾的缓解剂;镇痛增强剂;抗肥胖或食欲抑制剂;治疗或预防认知障碍和失忆症的药物;治疗发育性认知异常的药物;治疗精神分裂症的药物;治疗神经退行性疾病的药物;抗抑郁或治疗情感障碍的药物;治疗或预防尿崩症的药物;治疗或预防多尿症的药物;或治疗低血压的药物。
  • CYCLOALKANOPYRIDINE DERIVATIVE
    申请人:BANYU PHARMACEUTICAL CO., LTD.
    公开号:EP1726590A1
    公开(公告)日:2006-11-29
    Provided are cycloalkanopyridine derivatives of formula [I]: [wherein the symbols are the same as those stated in the description]. The compounds act as a nociceptin receptor antagonist, and are useful as medicines for diseases associated with a nociceptin receptor, for example, as a reliever against tolerance to a narcotic analgesic; a reliever against dependence on or addiction to a narcotic analgesic; an analgesic enhancer; an antiobesitic or appetite suppressor; a treating or prophylactic agent for cognitive impairment and dementia/amnesia; an agent for treating developmental cognitive abnormality; a remedy for schizophrenia; an agent for treating neurodegenerative diseases; an anti-depressant or treating agent for affective disorder; a treating or prophylactic agent for diabetes insipidus; a treating or prophylactic agent for polyuria; or a remedy for hypotension.
    所提供的是式[I]的环烷吡啶衍生物: [其中符号与描述中的符号相同]。这些化合物具有痛觉素受体拮抗剂的作用,可作为治疗与痛觉素受体相关疾病的药物,例如,可作为麻醉镇痛剂耐受性的缓解剂;麻醉镇痛剂依赖或成瘾的缓解剂;镇痛增强剂;抗厌食或食欲抑制剂;治疗或预防认知障碍和痴呆/失忆症的药物;治疗发育性认知异常的药物;治疗精神分裂症的药物;治疗神经退行性疾病的药物;抗抑郁剂或治疗情感障碍的药物;治疗或预防糖尿病性尿崩症的药物;治疗或预防多尿症的药物;或治疗低血压的药物。
  • US7855294B2
    申请人:——
    公开号:US7855294B2
    公开(公告)日:2010-12-21
  • EP1726590
    申请人:——
    公开号:——
    公开(公告)日:——
  • Catalytic Friedel‐Crafts Reactions on Saturated Heterocycles and Small Rings for sp <sup>3</sup> ‐sp <sup>2</sup> Coupling of Medicinally Relevant Fragments
    作者:Rosemary A. Croft、Maryne A. J. Dubois、Alexander J. Boddy、Camille Denis、Anna Lazaridou、Anne Sophie Voisin‐Chiret、Ronan Bureau、Chulho Choi、James J. Mousseau、James A. Bull
    DOI:10.1002/ejoc.201900498
    日期:2019.9
    A systematic comparison of Lewis acid catalysts [Ca(II), Li(I) and Fe(III)] is presented for catalytic Friedel–Crafts reactions using alcohols on 4‐, 5‐, and 6‐membered oxygen and nitrogen heterocycles and cyclobutanes, forming gem‐diaryl quaternary centers.
    路易斯酸催化剂[Ca(II),Li(I)和Fe(III)]的系统比较被提出用于使用醇在4、5和6元氧和氮杂环和环丁烷上进行的催化Friedel-Crafts反应,形成宝石-二芳基四元中心。
查看更多